Press Releases

Press Releases

October 09, 2018
International multiple sclerosis conference features 35 new studies using Simoa technology demonstrating potential of Neurofilament light chain (NfL) as a reliable and sensitive disease biomarker
September 26, 2018
New research marks the latest example of neurofilament light chain (NfL) as a critical biomarker for detecting brain injuries
September 18, 2018
Top researchers join the discussion on biomarker innovations for accelerating drug development Brief Quanterix business update to be provided as well
September 12, 2018
Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market
September 05, 2018
Company also attending Citi’s 13th Annual Biotech Conference
August 08, 2018
66% revenue growth Integration of Aushon in process  
August 06, 2018
Neurofilament light chain (NfL) proves to be a transformative biomarker for understanding wide range of neurological conditions and advancing clinical trials
July 23, 2018
New research advances the diagnosis of concussions and PTSD for those in the line of duty